2004•Southern China Journal of Dermato-VenereologyRequires access

Investigation on the Efficacy of 0.1% Tazarotene Gel in Treatment of Patients with Acne Vulgaris

Zhihua Wu

Open publisher page 0 citations

Abstract

Objective:To observe the clinical efficacy and safety of 0.1% tazarotene gel short-contact therapy adopted in treatment of mild or moderate facial acne. Methods:A randomized, parallel controlled clinical study was conducted. The patients were treated topically with trial drug, twice-daily (morning and evening) for 12 weeks. Results:Results showed that the effective rates were 24%,40%,60% and 68% respectively in study group at 2,4,8 and 12 weeks. In control group, the effective rates were 19.2% (P=0.631, compared to the study group), 23.1% (P=0.175), 30.8% (P=0.034) and 30.8% (P=0.008) respectively. Conclusion:Short-contact treatment of 0.1% tazarotene gel for mild to moderate facial acne was effective, safe and well tolerated.

About this research paper

What this paper is about

Objective:To observe the clinical efficacy and safety of 0.1% tazarotene gel short-contact therapy adopted in treatment of mild or moderate facial acne. Methods:A randomized, parallel controlled clinical study was conducted. The patients were treated topically with trial drug, twice-daily (morning and evening) for 12 weeks. Results:Results showed that the effective rates were 24%,40%,60% and 68% respectively in study group at 2,4,8 and 12 weeks. In control group, the effective rates were 19.2% (P=0.631, compared to the study group), 23.1% (P=0.175), 30.8% (P=0.034) and 30.8% (P=0.008) respectively. Conclusion:Short-contact treatment of 0.1% tazarotene gel for mild to moderate facial acne was effective, safe and well tolerated.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the clinical efficacy and safety of 0.1% tazarotene gel short-contact therapy adopted in treatment of mild or moderate facial acne. Methods:A randomized, parallel controlled clinical study was conducted. The patients were treated topically with trial drug, twice-daily (morning and evening) for 12 weeks. Results:Results showed that the effective rates were 24%,40%,60% and 68% respectively in study group at 2,4,8 and 12 weeks. In control group, the effective rates were 19.2% (P=0.631, compared to the study group), 23.1% (P=0.175), 30.8% (P=0.034) and 30.8% (P=0.008) respectively. Conclusion:Short-contact treatment of 0.1% tazarotene gel for mild to moderate facial acne was effective, safe and well tolerated.

Key concepts: Tazarotene, Acne, Medicine, Evening, Morning, Dermatology, Clinical efficacy, Clinical trial

Related papers

Back to paper searchBrowse research topicsOriginal source
Investigation on the Efficacy of 0.1% Tazarotene Gel in Treatment of Patients with Acne Vulgaris — Research Paper | ScholarLens